UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4258) 4258
life sciences & biomedicine (3725) 3725
humans (3287) 3287
animals (2774) 2774
phosphorylation (1380) 1380
cell biology (1368) 1368
mice (1338) 1338
focal adhesion kinase (1157) 1157
cells, cultured (1023) 1023
signal transduction (1023) 1023
cell line, tumor (1022) 1022
cell movement - drug effects (1017) 1017
oncology (959) 959
focal adhesion protein-tyrosine kinases - metabolism (896) 896
male (893) 893
biochemistry & molecular biology (864) 864
signal transduction - drug effects (853) 853
rats (833) 833
protein-tyrosine kinases - metabolism (815) 815
proteins (790) 790
focal adhesion kinase 1 - metabolism (786) 786
female (775) 775
focal adhesion protein-tyrosine kinases (765) 765
kinases (759) 759
cell adhesion - drug effects (716) 716
focal adhesion kinase 1 (698) 698
phosphorylation - drug effects (678) 678
cell adhesion & migration (640) 640
cell adhesion (604) 604
focal adhesions - metabolism (569) 569
cell line (564) 564
cell proliferation - drug effects (558) 558
focal adhesions - drug effects (525) 525
cancer (502) 502
cell migration (496) 496
apoptosis (486) 486
actins - metabolism (473) 473
research (448) 448
metastasis (446) 446
gene expression (439) 439
integrins (435) 435
analysis (407) 407
fak (400) 400
src-family kinases - metabolism (400) 400
enzyme inhibitors - pharmacology (395) 395
focal adhesions (393) 393
science & technology - other topics (393) 393
cell proliferation (380) 380
research article (377) 377
cytoskeleton (371) 371
apoptosis - drug effects (363) 363
adhesion (359) 359
multidisciplinary sciences (348) 348
paxillin (344) 344
dose-response relationship, drug (341) 341
enzyme activation - drug effects (336) 336
medicine (334) 334
signal transduction - physiology (334) 334
actin (332) 332
physiology (332) 332
blotting, western (328) 328
tyrosine - metabolism (327) 327
transfection (319) 319
extracellular matrix (317) 317
cell movement (308) 308
time factors (306) 306
cell adhesion molecules - metabolism (305) 305
protein kinase inhibitors - pharmacology (305) 305
proto-oncogene proteins c-akt - metabolism (299) 299
cell survival - drug effects (296) 296
migration (294) 294
physiological aspects (294) 294
tumors (294) 294
antineoplastic agents - pharmacology (288) 288
biology (280) 280
phosphoproteins - metabolism (280) 280
pharmacology & pharmacy (279) 279
rats, sprague-dawley (279) 279
neoplasm invasiveness (274) 274
tyrosine (271) 271
focal adhesion protein-tyrosine kinases - antagonists & inhibitors (269) 269
cell movement - physiology (267) 267
tumor cells, cultured (267) 267
cell adhesion - physiology (265) 265
phosphatidylinositol 3-kinases - metabolism (258) 258
cytoskeleton - metabolism (257) 257
science (256) 256
focal adhesion (255) 255
neurosciences (250) 250
neurosciences & neurology (250) 250
focal adhesion kinase 1 - genetics (247) 247
breast cancer (245) 245
integrins - metabolism (244) 244
angiogenesis (242) 242
cytoskeletal proteins - metabolism (242) 242
enzyme activation (242) 242
cells (234) 234
signaling (231) 231
technology (226) 226
cytoskeleton - drug effects (224) 224
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5300) 5300
Chinese (44) 44
Japanese (18) 18
Portuguese (3) 3
French (2) 2
Russian (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International journal of oncology, ISSN 1019-6439, 11/2017, Volume 51, Issue 5, pp. 1583 - 1589
Journal Article
Journal Article
Molecular neurobiology, ISSN 0893-7648, 8/2015, Volume 52, Issue 1, pp. 664 - 678
...) to the passage of chemotherapeutic drugs and T cells. T cell migration under AR signaling occurs primarily by paracellular transendothelial route... 
A2A adenosine receptor | Neurology | Neurosciences | Biomedicine | Tight and adherens junctions | Blood-brain barrier | Neurobiology | Paracellular permeability | Cell Biology | Rho-GTPase | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Stress Fibers - drug effects | Humans | Deoxycytidine - pharmacology | rhoA GTP-Binding Protein - metabolism | Antineoplastic Agents - therapeutic use | Receptors, Adenosine A2 - metabolism | Adherens Junctions - metabolism | Adenosine A2 Receptor Agonists - pharmacology | T-Lymphocytes - drug effects | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Phosphorylation - drug effects | Tight Junctions - drug effects | Tight Junctions - metabolism | Cell Line | Endothelial Cells - metabolism | Jurkat Cells | Mice, Inbred C57BL | Electric Impedance | Down-Regulation - drug effects | Blood-Brain Barrier - metabolism | Cell Movement - drug effects | Focal Adhesions - drug effects | Stress Fibers - metabolism | Animals | Signal Transduction - drug effects | T-Lymphocytes - cytology | Endothelial Cells - cytology | Cell Membrane Permeability - drug effects | Focal Adhesions - metabolism | Glioblastoma - pathology | Adherens Junctions - drug effects | Glioblastoma - drug therapy | Endothelial Cells - enzymology | Deoxycytidine - analogs & derivatives | Endothelial Cells - drug effects | Index Medicus
Journal Article
International journal of oncology, ISSN 1019-6439, 01/2013, Volume 42, Issue 1, pp. 83 - 92
Journal Article
Cell cycle (Georgetown, Tex.), ISSN 1551-4005, 10/2014, Volume 8, Issue 15, pp. 2435 - 2443
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 13, pp. 1527 - 1533
Purpose PF-00562271 is a novel inhibitor of focal adhesion kinase (FAK). The objectives of this study were to identify the recommended phase II dose (RP2D... 
Life Sciences & Biomedicine | Oncology | Science & Technology | United States | Humans | Middle Aged | Male | Positron-Emission Tomography | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Focal Adhesion Kinase 2 - antagonists & inhibitors | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Enzyme Inhibitors - pharmacokinetics | Focal Adhesion Kinase 2 - metabolism | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Radiopharmaceuticals | Focal Adhesion Kinase 1 - metabolism | Protein Kinase Inhibitors - pharmacokinetics | Drug Administration Schedule | Pyrimidines - administration & dosage | Neoplasms - enzymology | Treatment Outcome | Neoplasms - diagnostic imaging | Sulfonamides - pharmacokinetics | Neoplasms - drug therapy | Canada | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Cytochrome P-450 CYP3A Inhibitors | Cytochrome P-450 CYP3A - metabolism | Pyrimidines - adverse effects | Midazolam - metabolism | Pyrimidines - pharmacokinetics | Sulfonamides - adverse effects | Fluorodeoxyglucose F18 | Aged | Australia | Neoplasm Staging | Neoplasms - pathology | Nonlinear Dynamics | Focal Adhesion Kinase 1 - antagonists & inhibitors | Sulfonamides - administration & dosage | Index Medicus
Journal Article
Journal Article
Small (Weinheim an der Bergstrasse, Germany), ISSN 1613-6829, 04/2010, Volume 6, Issue 7, pp. 832 - 842
Journal Article
Journal Article